Oxford Capital

Type

Venture Capital

Status

Active

Location

Oxford, United Kingdom

Total investments

191

Average round size

4M

Portfolio companies

68

Rounds per year

7.64

Lead investments

30

Follow on index

0.64

Exits

16

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareFinTechAnalyticsMobileHealth CareHealth DiagnosticsTherapeuticsHardwareChemical

Summary

Oxford Capital Partners appeared to be the VC, which was created in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Oxford.

The typical startup value when the investment from Oxford Capital Partners is 10-50 millions dollars. The high activity for fund was in 2008. Despite it in 2019 the fund had an activity. The fund is generally included in 7-12 deals every year. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2011. Opposing the other organizations, this Oxford Capital Partners works on 20 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Oxford Capital Partners, startups are often financed by Oxford Technology Management, South East Growth Fund & Management, Herald Ventures. The meaningful sponsors for the fund in investment in the same round are Seraphim Capital, South East Growth Fund & Management, MTI. In the next rounds fund is usually obtained by Seraphim Capital, MTI, Carbon Trust.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Sphere Medical Holding, Celoxica, Veryan Medical We can highlight the next thriving fund investment areas, such as Health Care, Health Diagnostics.

The fund was created by David Mott, Edward Mott. We also calculated 18 valuable employees in our database.

Show more

Investor highlights

Industry focus
HealthcareClimate techFintechFuture of WorkMobility Show 1 more
Stage focus
SeedSeries A
Geo focus
United Kingdom
Check size
200K — 1M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
191
Lead investments
30
Exits
16
Rounds per year
7.64
Follow on index
0.64
Investments by industry
  • Software (66)
  • Biotechnology (46)
  • Health Care (26)
  • Analytics (25)
  • Health Diagnostics (22)
  • Show 120 more
Investments by region
  • United Kingdom (185)
  • United States (5)
  • France (1)
Peak activity year
2011
Number of Decacorns
1
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
181M
Group Appearance index
0.79
Avg. company exit year
10
Avg. multiplicator
1.05
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Curve 11 Jul 2017 Financial Services, FinTech, Payments, Apps, Banking Early Stage Venture 10M England, London, United Kingdom
Ittybit 05 Jun 2024 Software Seed 2M Greater Manchester, Manchester, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.